The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results from plasmaMATCH trial cohort E: A phase II trial of olaparib and ceralasertib in patients with triple-negative advanced breast cancer (CRUK/15/010).
 
Alistair E. Ring
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Lilly; MSD Oncology; Novartis; Pfizer; Roche UK; Seagen
 
Laura Moretti
No Relationships to Disclose
 
Angelica Afshari-Mehr
No Relationships to Disclose
 
Andrew M. Wardley
Employment - AstraZeneca; Outreach Research & Innovation Group Ltd
Leadership - Outreach research & Innovation Group Limited
Stock and Other Ownership Interests - Andrew Wardley Limited; AstraZeneca; Outreach Research & Innovation Group Limited
Honoraria - AstraZeneca; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Athenex; Athenex; Boehringer Ingelheim; Coleman Research; Daiichi Sankyo; Gerson Lehrman Group; Guidepoint Global; Helios; Lilly; MSD Oncology; Novartis; Pfizer; Roche; Silicon Motion Technology Corporation
Speakers' Bureau - AstraZeneca; Eisai; Lilly; Novartis; Pfizer; Roche
Research Funding - Daiichi-Sankyo (Inst); Lilly (Inst); Roche (Inst); seagn (Inst)
 
Lucy Kilburn
No Relationships to Disclose
 
Bora Gurel
No Relationships to Disclose
 
Iain R. MacPherson
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Gilead Sciences; In3Bio; Merck Sharp & Dohme (UK) Limited; Pfizer; Roche
Speakers' Bureau - Daiichi Sankyo UK Ltd
Research Funding - Allarity Therapeutics (Inst); AstraZeneca (Inst); Byondis (Inst); Celldex (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi/Aventis (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo; Gilead Sciences; Novartis Pharmaceuticals UK Ltd.
 
Richard D. Baird
Consulting or Advisory Role - AstraZeneca (Inst); Daiichi Sankyo (Inst); Molecular Partners (Inst); Novartis (Inst); Roche/Genentech (Inst); Shionogi (Inst)
Research Funding - AstraZeneca (Inst); Biomarin (Inst); Boehringer Ingelheim (Inst); Carrick Therapeutics (Inst); G1 Therapeutics (Inst); Genentech (Inst); Molecular Partners (Inst); Roche (Inst); Sanofi (Inst); Shionogi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo; Molecular Partners; Shionogi
 
Sue Martin
No Relationships to Disclose
 
Alex Pearson
No Relationships to Disclose
 
Rebecca Roylance
Leadership - Google health (I)
Honoraria - Daiichi Sankyo Europe GmbH; Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca
Consulting or Advisory Role - Daiichi Sankyo Europe GmbH; Daiichi Sankyo/Astra Zeneca; Iqvia; Lilly
Travel, Accommodations, Expenses - BMS; Daiichi Sankyo Europe GmbH; Daiichi Sankyo Europe GmbH; Roche/Genentech
 
Matthew Winter
Consulting or Advisory Role - Gilead Sciences; Lilly; Novartis
Speakers' Bureau - Lilly
Travel, Accommodations, Expenses - Lilly
 
Kathryn Dunne
No Relationships to Disclose
 
Ellen Copson
Honoraria - AstraZeneca; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - Lilly; NanoString Technologies; NanoString Technologies; Pfizer; Roche; Sanofi/Aventis
Speakers' Bureau - AstraZeneca; AstraZeneca; Pfizer; Pfizer; Roche; Sanofi/Aventis
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); SECA
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Tamas Hickish
Employment - IQ Health Tech
Leadership - IQ Health Tech
Stock and Other Ownership Interests - IQ Health Tech
Patents, Royalties, Other Intellectual Property - Bournemouth University
 
Peter Stephens
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Novartis; Pfizer
Speakers' Bureau - Exact Sciences
 
Russell J. Burcombe
Consulting or Advisory Role - GenesisCare
 
Katrina Randle
No Relationships to Disclose
 
Judith Bliss
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); GlaxoSmithKline/Novartis (Inst); Janssen-Cilag (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Nicholas C. Turner
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Repare Therapeutics; Roche; Taiho Pharmaceutical; Zeno pharmaceuticals
Research Funding - AstraZeneca (Inst); Bio-Rad (Inst); Clovis Oncology (Inst); Guardant Health (Inst); Inivata (Inst); InVitae (Inst); Natera (Inst); Personalis (Inst); Pfizer (Inst); Roche (Inst)